As of today (2024-05-01), Repligen's share price is $164.46.
Repligen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.32. Hence, Repligen's Price-to-Free-Cash-Flow Ratio for today is 124.31.
The historical rank and industry rank for Repligen's Price-to-Free-Cash-Flow or its related term are showing as below:
RGEN'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.97 Med: 148.15 Max: 7784
Current: 124.31
During the past 13 years, Repligen's highest Price-to-Free-Cash-Flow Ratio was 7784.00. The lowest was 13.97. And the median was 148.15.
RGEN's Price-to-Free-Cash-Flow is ranked worse than 88.59% of 333
companies
in the Medical Devices & Instruments industry
Industry Median: 32.6
vs RGEN: 124.31
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Repligen was 97.20% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 25.50% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 16.10% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 12.80% per year.
During the past 13 years, Repligen's highest 3-Year average Free Cash Flow per Share Growth Rate was 111.90% per year. The lowest was -58.10% per year. And the median was 10.30% per year.
Repligen Price-to-Free-Cash-Flow Historical Data
The historical data trend for Repligen's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Repligen's Price-to-Free-Cash-Flow
For the Medical Instruments & Supplies subindustry, Repligen's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Repligen's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Repligen's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Repligen's Price-to-Free-Cash-Flow falls into.
Repligen Price-to-Free-Cash-Flow Calculation
Repligen's Price-to-Free-Cash-Flow ratio for today is calculated as
Repligen's Share Price of today is $164.46. Repligen's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Repligen Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Repligen's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RGEN has been successfully added to your 